Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
D. Arnold, B. Lueza, J. Y. Douillard, M. Peeters, H. J. Lenz, A. Venook, V. Heinemann, E. Van Cutsem, J. P. Pignon, J. Tabernero, A. Cervantes, Fortunato Ciardiello
Dive into the research topics of 'Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials'. Together they form a unique fingerprint.